For the Inventor, By the Inventor

Enter inventor name

Seoul, South Korea

Jong-Mook Kim

USPTO Granted Patents = 13 (Patent Applications = 2)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 42(Granted Patents)

Company Filing History:

Viromed Co., Ltd.

Viromed Limited

Neuracle Genetics Inc.

Neuracle Science Co., Ltd.

Helixmith Co., Ltd

where one patent can have more than one assignee

Years Active: 2002-2025

where 'Filed Patents' based on already Granted Patents

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12215338 - Adeno-associated virus (AAV) delivery of anti-FAM19A5 antibodies (2025-02-04),

2. 12173304 - Intron fragments (2024-12-24),

3. RE48404 - Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor (2021-01-25),

4. 8389492 - Lyophilized DNA formulations for enhanced expression of plasmid DNA (2013-03-05),

5. 8338385 - Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor (2012-12-25),

6. 8106158 - Compositions and methods for fusion protein separation (2012-01-31),

7. 7838505 - Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor (2010-11-23),

8. 7812146 - Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor (2010-10-12),

9. 7745174 - Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor (2010-06-29),

10. 7585943 - Compositions and methods for fusion protein separation (2009-09-08),

11. 7175840 - Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof (2007-02-13),

12. 6838280 - Construction of high efficiency retroviral vector for gene therapy of hunter syndrome (2005-01-04),

13. 6451595 - High efficiency retroviral vectors that contain none of viral coding sequences (2002-09-17),

Title: The Innovations of Jong-Mook Kim

Introduction

Jong-Mook Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of gene delivery systems. With a total of 13 patents to his name, Kim's work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

One of Jong-Mook Kim's latest patents involves the use of adeno-associated virus (AAV) delivery of anti-FAM19A5 antibodies. This patent provides AAV vectors that encode an antagonist against the FAM19A5 protein, which is crucial for developing targeted therapies. Another notable patent focuses on novel intron fragments that can enhance gene expression. These intron fragments can achieve expression levels comparable to full-length introns while allowing for the loading of larger transgenes in genetic information delivery systems, such as AAVs and rhabdoviruses. This innovation is expected to broaden the range of therapeutic genes available for treatment.

Career Highlights

Throughout his career, Jong-Mook Kim has worked with various companies, including Viromed Co., Ltd. and Viromed Limited. His experience in these organizations has contributed to his expertise in biotechnology and patent development.

Collaborations

Jong-Mook Kim has collaborated with notable colleagues, including Woong Hahn and Eun-Jin Park. These partnerships have likely facilitated the advancement of his research and innovations in the field.

Conclusion

Jong-Mook Kim's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the industry. His work continues to pave the way for advancements in gene therapy and medical treatments.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…